Target intelligence / Profile preview

Microbial adhesin

Molecular classification
Surface protein, Lectin, Pilin, MSCRAMM, Autotransporter protein
01

Overview

Microbial adhesins are specialized surface proteins or appendages, such as fimbriae and pili, that pathogens use to attach to host cells or the extracellular matrix (Asadi et al., 2019). This attachment is the crucial first step in the colonization and infection process, allowing the microbe to resist mechanical clearance by host fluids like urine or mucus (Krachler & Orth, 2013). Adhesins typically function by binding to specific carbohydrate or protein ligands on the host surface with high affinity and specificity. Because they are essential for virulence but not for the survival of the microbe outside the host, they are attractive targets for anti-adhesion therapies (Ofek et al., 2003). These therapies aim to block the binding site of the adhesin using small molecule inhibitors, such as mannosides, or antibodies, thereby preventing the initiation of disease. This approach is particularly valuable in the era of multi-drug resistance, as it exerts less selective pressure for the development of resistance compared to traditional bactericidal antibiotics (Foster et al., 2014). While promising, challenges include the high diversity of adhesins across different strains and the need to maintain the integrity of the host's beneficial commensal flora.

Other names
Bacterial adhesinViral attachment proteinFungal adhesinAdhesion proteinMSCRAMM (Microbial Surface Components Recognizing Adhesive Matrix Molecules)
02

Mechanism of action

Competitive inhibition of microbial attachment to host cell receptors or extracellular matrix components, preventing colonization and biofilm formation (Krachler & Orth, 2013).

03

Biological functions

Cell adhesionPathogen colonizationBiofilm formationHost-pathogen interactionImmune evasion
04

Disease associations

InfectionUrinary tract infectionRespiratory infectionGastrointestinal infectionSepsis
05

Safety considerations

Potential disruption of commensal microbiota (Ofek et al., 2003)High specificity requirements to avoid host glycan interferenceRapid renal clearance of small molecule inhibitorsRedundancy of adhesins in some pathogens
06

Interacting drugs

Sibofimloc (EB8018)

4 more in the full profile.

07

Biomarkers

Adhesin gene presence (e.g., fimH, papG)Bacterial adhesion capacityBiofilm density

Beyond the preview

Go deeper on Microbial adhesin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial adhesin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call